A novel vaccine has shown promise in protecting against C. diff disease and recurrence. The vaccine, which targets mucosal areas, has been found to clear C. diff colonization in preclinical studies. Research into C. diff infections and potential treatments, including vaccines and antibiotics, is ongoing, with various studies exploring the mechanisms of the disease and emerging therapeutic strategies.